Maternal RSV vaccine and nirsevimab sharply cut infant hospitalizations, new data show
RSV’s Downfall? Maternal Vaccines and Nirsevimab Show Promise, But Future Trends Demand Vigilance Respiratory Syncytial Virus (RSV) has long been a dreaded foe of young infants, packing pediatric wards each winter. But recent data offers a glimmer of hope: widespread use of maternal RSV vaccines and nirsevimab, a monoclonal antibody, led to a dramatic decrease … Read more